These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38917633)

  • 1. RNA editing enzyme ADAR2 regulates P-glycoprotein expression in murine breast cancer cells through the circRNA-miRNA pathway.
    Omata Y; Haraguchi M; Yoshinaga S; Ogino T; Okawa M; Tsuruta A; Koyanagi S; Ohdo S
    Biochem Biophys Res Commun; 2024 Sep; 726():150289. PubMed ID: 38917633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA editing enzyme ADAR1 controls miR-381-3p-mediated expression of multidrug resistance protein MRP4 via regulation of circRNA in human renal cells.
    Omata Y; Okawa M; Haraguchi M; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
    J Biol Chem; 2022 Aug; 298(8):102184. PubMed ID: 35753353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
    Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
    RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism.
    Widmark A; Sagredo EA; Karlström V; Behm M; Biryukova I; Friedländer MR; Daniel C; Öhman M
    J Biol Chem; 2022 Mar; 298(3):101682. PubMed ID: 35124003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
    Nakano M; Fukami T; Gotoh S; Nakajima M
    J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298.
    Bao L; Hazari S; Mehra S; Kaushal D; Moroz K; Dash S
    Am J Pathol; 2012 Jun; 180(6):2490-503. PubMed ID: 22521303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
    Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
    FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
    Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
    Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma.
    Tomaselli S; Galeano F; Alon S; Raho S; Galardi S; Polito VA; Presutti C; Vincenti S; Eisenberg E; Locatelli F; Gallo A
    Genome Biol; 2015 Jan; 16(1):5. PubMed ID: 25582055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of ADAR mRNA expression in patients with congenital heart defects.
    Altaf F; Vesely C; Sheikh AM; Munir R; Shah STA; Tariq A
    PLoS One; 2019; 14(4):e0200968. PubMed ID: 31039163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide enhances ADAR2 which drives Hirschsprung's disease by impairing miR-142-3p biogenesis.
    Peng L; Zhang H; Su Y; Shen Q; Du C; Xie H; Li H; Yan J; Shen Z; Jiang W; Xia Y; Xu X; Tang W
    J Cell Mol Med; 2018 Sep; 22(9):4045-4055. PubMed ID: 29956457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR2 Regulates Malignant Behaviour of Mesothelioma Cells Independent of RNA-editing Activity.
    Sakata KI; Maeda K; Sakurai N; Liang S; Nakazawa S; Yanagihara K; Kubo T; Yoshiyama H; Kitagawa Y; Hamada JI; Iizasa H
    Anticancer Res; 2020 Mar; 40(3):1307-1314. PubMed ID: 32132027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA editing enzyme ADAR1 governs the circadian expression of P-glycoprotein in human renal cells by regulating alternative splicing of the ABCB1 gene.
    Omata Y; Yamauchi T; Tsuruta A; Matsunaga N; Koyanagi S; Ohdo S
    J Biol Chem; 2021; 296():100601. PubMed ID: 33781748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of 7-
    Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
    Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma.
    Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH
    Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
    Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
    Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.
    Yang W; Chendrimada TP; Wang Q; Higuchi M; Seeburg PH; Shiekhattar R; Nishikura K
    Nat Struct Mol Biol; 2006 Jan; 13(1):13-21. PubMed ID: 16369484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
    Hao J; Du X; Lv F; Shi Q
    J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer.
    Kim HS; Na MJ; Son KH; Yang HD; Kim SY; Shin E; Ha JW; Jeon S; Kang K; Moon K; Park WS; Nam SW
    Exp Mol Med; 2023 Jan; 55(1):95-107. PubMed ID: 36599932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.